SDM for Stroke Prevention in Atrial Fibrillation



Status:Enrolling by invitation
Conditions:Atrial Fibrillation
Therapuetic Areas:Cardiology / Vascular Diseases
Healthy:No
Age Range:18 - Any
Updated:8/18/2018
Start Date:September 2016
End Date:September 2021

Use our guide to learn which trials are right for you!

Shared Decision Making for Stroke Prevention in Atrial Fibrillation (SDM4Afib): A Randomized Trial

The objective of this project is to evaluate a treatment decision aid for patients with
atrial fibrillation.

The goal of this study is to determine the extent to which the Anticoagulation Choice tool
promotes shared decision making and its impact on anticoagulation use and adherence versus
standard care in patients with nonvalvular atrial fibrillation.

Clinician Inclusion Criteria:

• All clinicians (MDs, NP/PAs, PharmDs) that are responsible for the modality of
Anticoagulation in eligible AF patients at participating sites, without exclusion

Patient Inclusion Criteria:

- ≥ 18 years of age

- Chronic nonvalvular atrial fibrillation deemed at high risk of thromboembolic strokes
(CHA2D2-VASc Score ≥ 1, or 2 in women)

- Able to read and understand (despite cognitive, sensorial, hearing or language
challenges) the informed consent document as determined by the study coordinator
during consent

Patient Exclusion Criteria:

• Clinician indicates that patient is not a candidate for a discussion about
anticoagulation medication
We found this trial at
3
sites
Minneapolis, Minnesota 55414
?
mi
from
Minneapolis, MN
Click here to add this to my saved trials
200 First Street SW
Rochester, Minnesota 55905
507-284-2511
Mayo Clinic Rochester Mayo Clinic is a nonprofit worldwide leader in medical care, research and...
?
mi
from
Rochester, MN
Click here to add this to my saved trials
1665 Utica Avenue South
Saint Louis Park, Minnesota 55416
?
mi
from
Saint Louis Park, MN
Click here to add this to my saved trials